vs
MARAVAI LIFESCIENCES HOLDINGS, INC.（MRVI）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
MARAVAI LIFESCIENCES HOLDINGS, INC.的季度营收约是RBB Bancorp的1.5倍（$49.9M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -71.6%，领先103.0%），RBB Bancorp同比增速更快（12.6% vs -11.8%），RBB Bancorp自由现金流更多（$42.6M vs $-24.9M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs -11.9%）
Maravai生命科学控股是一家全球化生命科学企业，专注于开发供应关键试剂、诊断产品及技术解决方案，服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域，客户覆盖全球相关科研、医疗和企业机构。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
MRVI vs RBB — 直观对比
营收规模更大
MRVI
是对方的1.5倍
$32.3M
营收增速更快
RBB
高出24.4%
-11.8%
净利率更高
RBB
高出103.0%
-71.6%
自由现金流更多
RBB
多$67.5M
$-24.9M
两年增速更快
RBB
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.9M | $32.3M |
| 净利润 | $-35.7M | $10.2M |
| 毛利率 | 25.8% | — |
| 营业利润率 | -117.9% | 39.5% |
| 净利率 | -71.6% | 31.5% |
| 营收同比 | -11.8% | 12.6% |
| 净利润同比 | -37.7% | 132.1% |
| 每股收益（稀释后） | $-0.24 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRVIRBB
| Q4 25 | $49.9M | $32.3M | ||
| Q3 25 | $41.6M | $32.6M | ||
| Q2 25 | $47.4M | $35.8M | ||
| Q1 25 | $46.9M | $28.5M | ||
| Q4 24 | $56.6M | $28.7M | ||
| Q3 24 | $69.0M | $30.3M | ||
| Q2 24 | $69.4M | $27.5M | ||
| Q1 24 | $64.2M | $28.2M |
净利润MRVIRBB
| Q4 25 | $-35.7M | $10.2M | ||
| Q3 25 | $-25.6M | $10.1M | ||
| Q2 25 | $-39.6M | $9.3M | ||
| Q1 25 | $-29.9M | $2.3M | ||
| Q4 24 | $-25.9M | $4.4M | ||
| Q3 24 | $-97.1M | $7.0M | ||
| Q2 24 | $-9.8M | $7.2M | ||
| Q1 24 | $-12.1M | $8.0M |
毛利率MRVIRBB
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
营业利润率MRVIRBB
| Q4 25 | -117.9% | 39.5% | ||
| Q3 25 | -98.6% | 40.7% | ||
| Q2 25 | -139.8% | 36.1% | ||
| Q1 25 | -104.9% | 11.2% | ||
| Q4 24 | -66.7% | 17.6% | ||
| Q3 24 | -239.9% | 31.6% | ||
| Q2 24 | -19.4% | 35.6% | ||
| Q1 24 | -29.4% | 39.9% |
净利率MRVIRBB
| Q4 25 | -71.6% | 31.5% | ||
| Q3 25 | -61.4% | 31.2% | ||
| Q2 25 | -83.5% | 26.1% | ||
| Q1 25 | -63.9% | 8.0% | ||
| Q4 24 | -45.8% | 15.3% | ||
| Q3 24 | -140.6% | 23.1% | ||
| Q2 24 | -14.1% | 26.4% | ||
| Q1 24 | -18.8% | 28.4% |
每股收益（稀释后）MRVIRBB
| Q4 25 | $-0.24 | $0.59 | ||
| Q3 25 | $-0.18 | $0.59 | ||
| Q2 25 | $-0.27 | $0.52 | ||
| Q1 25 | $-0.21 | $0.13 | ||
| Q4 24 | $-0.21 | $0.26 | ||
| Q3 24 | $-0.68 | $0.39 | ||
| Q2 24 | $-0.07 | $0.39 | ||
| Q1 24 | $-0.09 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9M | $212.3M |
| 总债务越低越好 | $291.8M | $119.9M |
| 股东权益账面价值 | $212.4M | $523.4M |
| 总资产 | $770.6M | $4.2B |
| 负债/权益比越低杠杆越低 | 1.37× | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资MRVIRBB
| Q4 25 | $216.9M | $212.3M | ||
| Q3 25 | $243.6M | $234.9M | ||
| Q2 25 | $269.9M | $191.9M | ||
| Q1 25 | $285.1M | $238.8M | ||
| Q4 24 | $322.4M | $257.7M | ||
| Q3 24 | $578.2M | $349.4M | ||
| Q2 24 | $573.2M | $252.8M | ||
| Q1 24 | $561.7M | — |
总债务MRVIRBB
| Q4 25 | $291.8M | $119.9M | ||
| Q3 25 | $292.8M | $119.8M | ||
| Q2 25 | $293.9M | $119.7M | ||
| Q1 25 | $294.9M | $119.6M | ||
| Q4 24 | $295.9M | $119.5M | ||
| Q3 24 | $521.7M | $119.4M | ||
| Q2 24 | $522.5M | $119.3M | ||
| Q1 24 | $523.3M | $119.2M |
股东权益MRVIRBB
| Q4 25 | $212.4M | $523.4M | ||
| Q3 25 | $245.4M | $514.3M | ||
| Q2 25 | $265.9M | $517.7M | ||
| Q1 25 | $300.6M | $510.3M | ||
| Q4 24 | $325.3M | $507.9M | ||
| Q3 24 | $344.9M | $509.7M | ||
| Q2 24 | $434.7M | $511.3M | ||
| Q1 24 | $410.7M | $514.0M |
总资产MRVIRBB
| Q4 25 | $770.6M | $4.2B | ||
| Q3 25 | $849.2M | $4.2B | ||
| Q2 25 | $897.0M | $4.1B | ||
| Q1 25 | $959.8M | $4.0B | ||
| Q4 24 | $1.0B | $4.0B | ||
| Q3 24 | $1.3B | $4.0B | ||
| Q2 24 | $1.4B | $3.9B | ||
| Q1 24 | $1.4B | $3.9B |
负债/权益比MRVIRBB
| Q4 25 | 1.37× | 0.23× | ||
| Q3 25 | 1.19× | 0.23× | ||
| Q2 25 | 1.11× | 0.23× | ||
| Q1 25 | 0.98× | 0.23× | ||
| Q4 24 | 0.91× | 0.24× | ||
| Q3 24 | 1.51× | 0.23× | ||
| Q2 24 | 1.20× | 0.23× | ||
| Q1 24 | 1.27× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.8M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-24.9M | $42.6M |
| 自由现金流率自由现金流/营收 | -49.9% | 131.8% |
| 资本支出强度资本支出/营收 | 4.2% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-70.7M | $73.5M |
8季度趋势，按日历期对齐
经营现金流MRVIRBB
| Q4 25 | $-22.8M | $43.4M | ||
| Q3 25 | $-15.2M | $2.1M | ||
| Q2 25 | $-10.3M | $21.7M | ||
| Q1 25 | $-9.4M | $7.8M | ||
| Q4 24 | $-14.6M | $58.5M | ||
| Q3 24 | $13.1M | $24.5M | ||
| Q2 24 | $17.4M | $11.7M | ||
| Q1 24 | $-8.5M | $4.8M |
自由现金流MRVIRBB
| Q4 25 | $-24.9M | $42.6M | ||
| Q3 25 | $-18.1M | $1.8M | ||
| Q2 25 | $-13.1M | $21.6M | ||
| Q1 25 | $-14.6M | $7.6M | ||
| Q4 24 | $-20.5M | $57.7M | ||
| Q3 24 | $4.5M | $24.2M | ||
| Q2 24 | $7.9M | $11.5M | ||
| Q1 24 | $-14.1M | $4.7M |
自由现金流率MRVIRBB
| Q4 25 | -49.9% | 131.8% | ||
| Q3 25 | -43.4% | 5.4% | ||
| Q2 25 | -27.7% | 60.2% | ||
| Q1 25 | -31.2% | 26.7% | ||
| Q4 24 | -36.2% | 201.0% | ||
| Q3 24 | 6.6% | 80.0% | ||
| Q2 24 | 11.4% | 42.0% | ||
| Q1 24 | -22.0% | 16.6% |
资本支出强度MRVIRBB
| Q4 25 | 4.2% | 2.5% | ||
| Q3 25 | 7.0% | 1.1% | ||
| Q2 25 | 6.1% | 0.3% | ||
| Q1 25 | 11.2% | 0.6% | ||
| Q4 24 | 10.3% | 2.7% | ||
| Q3 24 | 12.4% | 0.8% | ||
| Q2 24 | 13.8% | 0.5% | ||
| Q1 24 | 8.8% | 0.5% |
现金转化率MRVIRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RBB
暂无分部数据
